Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

SmartTechGroup reported for 2024 by IFRS

4/30/25 CARM

Southern Kuzbass reports for 2024 by IFRS

4/30/25 UKUZ

Alrosa reported for 3 months of 2025 by RAS

4/30/25 ALRS

Rosseti South reported for 3 months of 2025 by RAS

4/30/25 MRKY

DZRD reported for 2024 by IFRS

4/30/25 DZRD

Krasnoyarskenergosbyt” reported for 3 months of 2025 by RAS

4/30/25 KRSB

Inter RAO's output in Q1 increased by 0.6%

4/30/25 IRAO

Inter RAO reported for 3 months of 2025 by RAS

4/30/25 IRAO

Rosseti Center reported for 3 months of 2025 by RAS

4/30/25 MRKC

Rosseti Center and Volga Region” reported for 3 months of 2025 by RAS

4/30/25 MRKP